Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Takeda and IDT Collaborate on Johnson & Johnson COVID-19 Vaccine Manufacturing
Tuesday, March 16, 2021Takeda Pharmaceutical Company Limited has just announced a mutual agreement with IDT Biologika GmbH IDT a development organization and contract manufacturing to utilize previously reserved IDT capacity for Takedas Dengue Vaccine Candidate TAK
Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations
Tuesday, March 16, 2021Gilead Sciences Incand Merck known as MSD outside the United States and Canada today announced that they have entered into an agreement to codevelop and cocommercialize longacting treatments in HIV that combine Gileads investigational capsid inhibito...
HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases
Monday, March 15, 2021HepaTx Corporation Namocell Inc and Takara Bio USA Inc TBUSA announced successful completion of the second phase of their collaboration on single cell analysis of hepatocytelike cells iHeps differentiated from adipose tissuederived stromal cells ASCs...
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
Friday, March 12, 2021PhaseBio Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases and BioVectra Inc an innovative global contract development and manufacturing orga...
Orgenesis Enters Second Phase of Collaboration with Hospital Infantil Universitario Niño Jesús
Friday, March 12, 2021Orgenesis Inc a global biotech company working to unlock the full potential of cell and gene therapies announces that it has entered the planned second phase of a collaboration with Hospital Infantil Universitario Nio Jess in Madrid Spain
Takeda Acquires Maverick Therapeutics to Advance T-Cell Activator Solid Tumor Treatments and Expand New Cancer Immunotherapy Portfolio
Thursday, March 11, 2021Takeda Pharmaceutical Company Limited announced the exercise of its option right to acquire Maverick Therapeutics Inc a privately held biopharmaceutical company pioneer in targeted and conditionally active bispecific Tcell immunotherapies
Complix Signs Global Drug Discovery and Development Agreement with I-Mab
Thursday, March 11, 2021Complix a biopharmaceutical company developing a pipeline of transformative Alphabody therapeutics announces that it has signed a significant drug discovery deal with IMab Nasdaq IMAB an innovationdriven clinical stage biopharmaceutical company commi...
Sparta Biopharma Announces US Commercial Availability of BioEnthesis™ for Rotator Cuff Repair
Wednesday, March 10, 2021Sparta Biopharma Inc a privatelyheld company developing osteobiologics for sports medicine announces the availability of BioEnthesisTM the firstofitskind allograft that has both mineralized and demineralized layers which provide the requisite propert...
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
Wednesday, March 10, 2021NeuroRx Inc and TFF Pharmaceuticals Inc are announcing that the companies have entered into a feasibility and material transfer agreement Feasibility Agreement Under the Feasibility Agreement NeuroRx is delivering ZYESAMI aviptadil synthetic VIP mate...
Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes
Tuesday, March 09, 2021Eli Lilly and Company and Biolojic Design Ltd Biolojic a biotechnology company that computationally designs functional antibodies today announced a research collaboration and license agreement that will leverage Biolojics AIbased multibody platform t...
